Novartis recalls 4 million bottles of Maalox for packaging flaws

Novartis AG recalled 4.4 million bottles of its antacid medicine Maalox because the lot numbers or expiration dates weren't legible on the outer plastic packaging, U.S. regulators said.

Novartis initiated the voluntary recall on Aug. 6 for nine different types of the chewable tablets, including Extra Strength and Advanced Maximum Strength Antacid and Antigas. The recall from the Basel, Switzerland-based drugmaker included bottles of tablets in Wild Berry, Assorted Fruit, Wintergreen, Mint and Cherry flavors, according to a posting on the Food and Drug Administration's website.

Novartis, the largest pharmaceutical company in Europe, recalled certain lots of the pain reliever Excedrin and the anti-sleeping pills No Doz beginning June 6 because their pouches may not have been fully sealed, the FDA said.